Locations:
Search IconSearch

Image of Note: 3-D Printing in Congenital Heart Disease

3-D replica informs an innovative operation in a deeply cyanosed child

3D heart

By Patcharapong Suntharos, MD, and Hani Najm, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ethan is a 9-year-old boy with heterotaxy syndrome that was characterized by complex congenital heart disease involving the following:

  • Situs inversus
  • Complete common atrioventricular canal
  • Total anomalous pulmonary venous return (TAPVR)
  • Left superior and inferior vena cavae to the left-sided atrium
  • Two good-sized D-loop ventricles with the aorta arising from the right ventricle remote from the ventricular septal defect
  • Pulmonary atresia with multiple major aortopulmonary collateral arteries (MAPCAs)

As an infant, he underwent TAPVR repair with anastomosis of the pulmonary venous confluence to the right side of the common atrium followed by unifocalization of his MAPCAs to a 12-mm aortic homograft-valved conduit connected to the right ventricle. He later underwent nine cardiac catheterizations, mainly to alleviate significant pulmonary artery branch stenoses and augment pulmonary artery blood flow. Nevertheless, he still had profound cyanosis.

In July 2016, we needed to innovate a procedure to improve oxygen saturation values in this deeply cyanosed child, but standard imaging modalities were inadequate for surgical planning. Building on Cleveland Clinic’s experience developing 3-D-printed heart replicas to plan transcatheter pulmonary valve implantations in patients with congenital defects, we decided to generate a 3-D-printed model of Ethan’s heart to assist our planning.

Using contrast-enhanced MRIs and CTs of his heart, we developed the 3-D-printed model shown above, which allowed us to examine the probability of whether a procedure could improve his oxygen saturations. When the surgeon (co-author Hani Najm, MD) was able to hold the exquisitely detailed heart replica in hand and make an incision in it, the feasibility of our proposed novel procedure was demonstrated.

Advertisement

That procedure was executed in real life exactly as planned on the 3-D replica, and the outcome was excellent. Ethan is now doing very well, with saturation percentages in the low 90s — a level he had never achieved before.

3-D-printed heart replicas are exceptional tools for planning percutaneous and surgical interventions for complex congenital heart defects. Our team looks forward to more opportunities to apply this technology in previously untreatable cases.

Dr. Suntharos is a pediatric and congenital interventional cardiologist, and Dr. Najm is Chair of Pediatric and Congenital Heart Surgery, both at Cleveland Clinic.

Advertisement

Related Articles

illustration of human heart with a graft repair
Novel Technique for Aortic Stenosis and Patient-Prosthesis Mismatch With LVOT Obstruction

Modified-Bentall single-patch Konno enlargement (BeSPoKE) optimizes hemodynamics, facilitates future TAVR

red blood cells floating around a DNA double helix
CHIP Cardiology Clinics Are Needed as CHIP Diagnoses Rise

Cleveland Clinic’s new dedicated program offers nuanced care for a newly recognized cardiovascular risk factor

side-by-side photos of heart valves during surgery
Special Considerations in Mitral Valve Repair: Barlow’s Valve, Barlow’s Syndrome and Arrhythmias

Scenarios where experience-based management nuance can matter most

Dr. Krishna Aragam with a patient
Genomics in Action: Advancing Precision Care for Inherited Heart Disease

Introducing Krishna Aragam, MD, head of new integrated clinical and research programs in cardiovascular genomics

scan of an implanted stented heart valve
Transcatheter Mitral Valve Replacement: Progress for the Most Challenging Mitral Valve Cases

How Cleveland Clinic is using and testing TMVR systems and approaches

illustrations of two valve procedures with "Vs." overlay spanning them
M-TEER or Surgical Repair? PRIMARY Trial Aims to Define Which Patients Are Best Served by Each

NIH-funded comparative trial will complete enrollment soon

full-color echocardiogram of the heart
Options for Mitral Regurgitation When Surgery Isn’t Ideal: The Maturing Roles of M-TEER

How Cleveland Clinic is helping shape the evolution of M-TEER for secondary and primary MR

two CT scans showing calcification of the mitral valve
Mitral Annular Calcification: Despite Its Challenges, Treatment Success Is Achievable

Optimal management requires an experienced center

Ad